Elevated Capital Advisors’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.16K Hold
35
﹤0.01% 660
2026
Q1
$2.05K Hold
35
﹤0.01% 652
2025
Q4
$1.98K Buy
+35
New +$1.91K ﹤0.01% 628
2023
Q3
Sell
-42,824
Closed -$1.42M 169
2023
Q2
$1.42M Buy
42,824
+2,733
+7% +$93.4K 0.47% 77
2023
Q1
$1.41M Buy
40,091
+959
+2% +$36.2K 0.5% 73
2022
Q4
$1.56M Buy
39,132
+2,173
+6% +$85.4K 0.6% 61
2022
Q3
$1.31M Buy
+36,959
New +$1.48M 0.52% 66
2022
Q1
$1.28M Buy
+30,449
New +$1.3M 0.43% 84
2021
Q3
$905K Buy
+25,651
New +$963K 0.31% 100
2021
Q1
$881K Sell
23,063
-73
-0.3% -$2.75K 0.34% 97
2020
Q4
$867K Sell
23,136
-1,786
-7% -$63.9K 0.38% 86
2020
Q3
$895K Sell
24,922
-691
-3% -$24.2K 0.42% 82
2020
Q2
$883K Buy
+25,613
New +$981K 0.41% 89
2019
Q4
$378K Buy
+8,893
New +$335K 0.42% 72
2019
Q1
$710K Buy
+19,352
New +$704K 0.47% 79

Other funds holding BTI

Elevated Capital Advisors's BTI Position: Q2 2026 in Review

Elevated Capital Advisors held its British American Tobacco (BTI) position steady in Q2 2026 at 35 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #660.

Elevated Capital Advisors first reported a position in BTI in Q1 2019 and has held it in 15 quarters since. The position peaked at $1.56M in Q4 2022. 904 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • Elevated Capital Advisors held 35 shares of British American Tobacco worth $2.16K as of Q2 2026.
  • Elevated Capital Advisors left its British American Tobacco share count unchanged in Q2 2026.
  • British American Tobacco made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q2 2026, its #660 holding.
  • Elevated Capital Advisors first reported a position in British American Tobacco in Q1 2019 and has held it in 15 quarters since.
  • Elevated Capital Advisors's British American Tobacco position peaked at $1.56M in Q4 2022.
  • 904 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.